Early detection of persistent trophoblastic tumour by serum human chorionic gonadotrophin monitoring after molar pregnancy

Chinese Medical Journal

Volumn 112, Issue 3, 1999, Pages 260-263

  Ngan, Hextan Yuen Sheung ^a,b   Wong, Ling Chiu ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Molar pregnancy; Persistent trophoblastic tumour (PIT); Serum human chorionic gonadotrophin (hCG) monitoring

Indexed keywords

CHORIONIC GONADOTROPIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; FOLINIC ACID; HYDROXYUREA; METHOTREXATE; VINCRISTINE;

ARTICLE; FEMALE; HUMAN; HYDATIDIFORM MOLE; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MONITORING;

ADOLESCENT; ADULT; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; CHORIONIC GONADOTROPIN; DACTINOMYCIN; FEMALE; HUMANS; HYDATIDIFORM MOLE; METHOTREXATE; MIDDLE AGED; PREGNANCY; TROPHOBLASTIC NEOPLASMS; UTERINE NEOPLASMS;

EID: 0345040633     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Ma HK, Wong LC, Ngan HYS. The modern management of trophoblastic disease. In: Bonnar J, ed. Recent advances in obstetrics and gynaecology. Vol 16 London: Churchill Livingstone, 1990:3-23.
2. World Health Organization. Gestational trophoblastic disease. WHO Tech Rep Ser 1983;692:7-81.
3. FIGO Oncology Committee Report. Int J Gynecol Obstet 1992; 39:149-150.
4. Kohom EI. Evaluation of the criteria used to make the diagnosis of nonmetastatic gestational trophoblastic neoplasia (in comments). Gynecol Oncol 1993;48:139-147.
5. Bagshawe KD. Risk and prognostic factors in trophoblastic! neoplasia. Cancer 1976;38:1373-1385.
6. Goldstein DP, Berkowitz RS. Prophylactic chemotherapy of complete molar pregnancy. Semin Oncol 1995;22:157-160.
7. Wong LC, Choo YC, Ma HK. Methotrexate with citrovorum factor rescue in gestational trophoblastic disease. Am J Obstet Gynecol 1985;152:59-62.
8. Petrilli ES, Twiggs LB, Blessing JA, et al. Single-dose actinomycin-D treatment for nonmetastatic gestational trophoblastic disease: a prospective phase II trial of the Gynecologic Oncology Group. Cancer 1987;60:2173-2176.
9. Wong LC, Choo YC, Ma HK. Primary oral etoposide therapy in gestational trophoblastic disease: an update. Cancer 1986; 58: 14-17.
10. Sung HC, Wu PC, Yang HY. Reevaluation of 5-fluorouracil as a single therapeutic agent for gestational trophoblastic neoplasms. Am J Obstet Gynecol 1984;150:69-75.
11. Bagshawe KD. From methotrexate to EMA/CO. In: Szulman AE, Buchsbaum HJ, eds. Gestational trophoblastic disease. New York: Springer-Verlag, 1987:127-132.
12. Wong LC, Choo YC, Ma HK. Hepatic metastases in gestational trophoblastic disease. Obstet Gynecol 1986;67:107-111.
13. Newlands ES. VP-16 in combinations for first-line treatment of malignant germ-cell tumors and gestational choriocarcinoma. Semin Oncol 1985;12:37-41.
14. Berkowitz RS, Goldstein DP. Modified triple chemotherapy. In: Szulman AE, Buchsbaum HJ, eds. Gestational trophoblastic disease. New York: Springer-Verlag, 1987:146-154.